EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells

Asep Bayu iD, Siti Irma Rahmawati, Firmansyah Karim iD, Jonathan Ardhianto Panggabean iD, Dasilva Primarindu Nuswantari, Dwi Wahyu Indriani, Peni Ahmadi iD, Rendi Witular, Ni Luh Putu Indi Dharmayanti, Masteria Yunovilsa Putra iD

Molecules · 2024

DOI: 10.3390/molecules29061404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Asep Bayu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Jalan Raya Jakarta-Bogor KM 46, Cibinong, Bogor 16911, Indones…. Hauptthemen laut MEDLINE: Mitragyna, Lung Neoplasms, Secologanin Tryptamine Alkaloids. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research and Innovation Agency, Research Organization for Health, National Research and Innovation Agency (BRIN), Republic of Indonesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is an effective chemotherapeutic agent in the treatment of solid hematological and non-hematological carcinoma. However, its long-term usage could result in side effects, such as cardiomyopathy, chronic heart failure, neurotoxicity and cancer cell resistance. In this study, we reported the sensitivity enhancement of A549 human lung cancer cells on doxorubicin at a low dose (0.1 ppm) in combination with 10–60 ppm of crude and alkaloid extracts derived from the leaves of Kratom (Mitragyna speciosa (Korth.) Havil. Rubiaceae). A549 cancer cell lines were insensitive to the crude extract containing low mitragynine (MG) (4–5%), while these cells were moderately inhibited by the alkaloid extract containing 40–45% MG (IC50 of 48–55 ppm). The alkaloid extract was found to inhibit A549 cancer cells via apoptosis as suggested by the higher relative fluorescence intensity with Annexin compared to that in propidium iodide (PI), i.e., a positive Annexin and a negative PI. The combination of crude extract and doxorubicin sensitized A549 cancer cells to doxorubicin by 1.3 to 2.4 times, while the combination with the alkaloid induced a 2.6- to 3.4-fold increase in sensitivity. The calculated combination index (CI) for doxorubicin with the crude and alkaloid extracts was 0.6 and 0.3, respectively, showing potential synergistic combinations to reduce the level of dosage of doxorubicin used in chemotherapy. In addition, the synergistic enhancement effect of crude extract on the cytotoxic activity of doxorubicin provides insights into the plausibility of non-alkaloids to influence the biological activities of Kratom.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitragynaLung NeoplasmsSecologanin Tryptamine AlkaloidsHumansPlant ExtractsDoxorubicinAnnexins

Stichwörter der Autor:innen

Mitragyna speciosaalkaloidanticancercytotoxicitykratommitragynine

Substanzen

Plant ExtractsDoxorubicinSecologanin Tryptamine AlkaloidsAnnexins

Autor:innen und Institutionen

  • Research Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Jalan Raya Jakarta-Bogor KM 46, Cibinong, Bogor 16911, Indonesia.
  • Ministry of Health, Republic of Indonesia, Jalan HR Rasuna Said Blok X5 Kavling 4-9, Kuningan, South Jakarta 12950, Indonesia.
  • Research Organization for Health, National Research and Innovation Agency (BRIN), Jalan Raya Jakarta-Bogor KM. 46, Cibinong, Bogor 16911, Indonesia.

ORCID-Profile: Asep Bayu, Firmansyah Karim, Jonathan Ardhianto Panggabean, Peni Ahmadi, Masteria Yunovilsa Putra

Förderung

  • National Research and Innovation Agency
  • Research Organization for Health, National Research and Innovation Agency (BRIN), Republic of Indonesia

Zitieren

APA

Bayu, A., Rahmawati, S. I., Karim, F., Panggabean, J. A., Nuswantari, D. P., Indriani, D. W., Ahmadi, P., Witular, R., Dharmayanti, N. L. P. I., & Putra, M. Y. (2024). An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells. Molecules. https://doi.org/10.3390/molecules29061404

Vancouver

Bayu A, Rahmawati SI, Karim F, Panggabean JA, Nuswantari DP, Indriani DW, et al. An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells. Molecules. 2024. doi:10.3390/molecules29061404

BibTeX
@article{Bayu2024,
  author = {Bayu, Asep and Rahmawati, Siti Irma and Karim, Firmansyah and Panggabean, Jonathan Ardhianto and Nuswantari, Dasilva Primarindu and Indriani, Dwi Wahyu and Ahmadi, Peni and Witular, Rendi and Dharmayanti, Ni Luh Putu Indi and Putra, Masteria Yunovilsa},
  title = {An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29061404}
}
Kostenlos starten →